Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -32.61%4.2M | -83.50%3.08M | -93.53%2.01M | 168.76%58.41M | -68.08%2.53M | 5.16%6.23M | 265.88%18.67M | 1,009.92%30.99M | 5.89%21.73M | 126.88%7.91M |
| Cost of revenue | 275.82%50.8M | 40.38%13.52M | ||||||||
| Gross profit | -7.31%7.62M | -24.59%8.22M | ||||||||
| Operating expense | -94.15%-1.89M | 18.87%-2.23M | 42.66%-1.36M | -87.89%6.83M | -102.45%-1.57M | -1,355.22%-975K | -4,266.67%-2.75M | -5,668.29%-2.37M | 285.38%56.45M | -102.26%-776K |
| Staff costs | ---- | ---- | ---- | -24.50%8.48M | ---- | ---- | ---- | ---- | 5.01%11.23M | ---- |
| Depreciation and amortization | ---- | ---- | ---- | 96.63%759K | ---- | ---- | ---- | ---- | 8.73%386K | ---- |
| -Depreciation | ---- | ---- | ---- | 96.63%759K | ---- | ---- | ---- | ---- | 8.73%386K | ---- |
| Other operating expenses | ---- | ---- | ---- | -88.52%5.25M | ---- | ---- | ---- | ---- | 535.93%45.77M | ---- |
| Total other operating income | 94.15%1.89M | -18.87%2.23M | -42.66%1.36M | 709.08%7.66M | 102.45%1.57M | 1,355.22%975K | 4,266.67%2.75M | 5,668.29%2.37M | -73.72%947K | 104.81%776K |
| Operating profit | -15.46%6.09M | -75.20%5.31M | -89.92%3.36M | 101.63%784K | -52.85%4.1M | 20.26%7.21M | 314.68%21.42M | 1,077.34%33.35M | -1,186.45%-48.23M | 111.83%8.69M |
| Net non-operating interest income (expenses) | 68.09%-30K | 88.37%-10K | 77.38%-19K | 90.76%-323K | 95.33%-59K | 87.90%-94K | 90.06%-86K | 85.71%-84K | -98.52%-3.49M | -307.74%-1.26M |
| Non-operating interest expense | -68.09%30K | -88.37%10K | -77.38%19K | -90.76%323K | -95.33%59K | -87.90%94K | -90.06%86K | -85.71%84K | 98.52%3.49M | 307.74%1.26M |
| Net investment income | ||||||||||
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
| Income from associates and other participating interests | ||||||||||
| Special income (charges) | -1,703.33%-541K | -100.00%-30K | ||||||||
| Less:Write off | ---- | ---- | ---- | 1,703.33%541K | ---- | ---- | ---- | ---- | 100.00%30K | ---- |
| Other non-operating income (expenses) | 52.87%-5.3M | 96.46%-729K | 89.57%-3.33M | 7.20%-65.83M | 95.27%-2.07M | -236.80%-11.25M | -13.11%-20.61M | -463.76%-31.9M | -70.94M | -43.72M |
| Income before tax | 118.40%761K | 534.26%4.57M | -98.90%15K | 99.85%-80K | 105.43%1.97M | -320.47%-4.14M | 105.18%721K | 140.04%1.37M | -836.88%-51.75M | -866.76%-36.29M |
| Income tax | 193.42%223K | -123.60%-21K | -11.94%-75K | 100.98%312K | 100.67%214K | -26.21%76K | 334.21%89K | 54.42%-67K | -1,915.51%-31.95M | -1,792.57%-31.87M |
| Net income | 112.77%538K | 626.74%4.59M | -93.72%90K | 99.30%-392K | 101.63%1.76M | -118.33%-4.21M | -97.45%632K | -66.46%1.43M | -194.05%-55.63M | -1,528.31%-107.72M |
| Net income continuous operations | 112.77%538K | 626.74%4.59M | -93.72%90K | 98.02%-392K | 139.70%1.76M | -337.56%-4.21M | 104.55%632K | 143.89%1.43M | -171.83%-19.8M | 21.57%-4.42M |
| Net income discontinuous operations | ---- | ---- | ---- | --0 | --0 | --0 | --0 | --0 | -153.94%-35.83M | -883.84%-103.3M |
| Noncontrolling interests | 20.00%-8K | 1,275.00%110K | 60.00%-2K | 94.00%-203K | 96.64%-196K | -100.46%-10K | -98.80%8K | 98.66%-5K | -281.55%-3.39M | -1,691.72%-5.84M |
| Net income attributable to the company | 112.99%546K | 619.58%4.48M | -93.61%92K | 99.64%-189K | 101.91%1.95M | -120.18%-4.2M | -97.42%623K | -69.04%1.44M | -191.20%-52.25M | -1,394.89%-101.88M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 112.99%546K | 619.58%4.48M | -93.61%92K | 99.64%-189K | 101.91%1.95M | -120.18%-4.2M | -97.42%623K | -69.04%1.44M | -191.20%-52.25M | -1,394.89%-101.88M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 112.86%0.0009 | 640.00%0.0074 | -91.67%0.0002 | 99.65%-0.0003 | 101.89%0.0032 | -120.29%-0.007 | -97.51%0.001 | -68.83%0.0024 | -191.16%-0.0866 | -1,389.31%-0.1689 |
| Diluted earnings per share | 112.86%0.0009 | 640.00%0.0074 | -91.67%0.0002 | 99.65%-0.0003 | 101.89%0.0032 | -120.29%-0.007 | -97.51%0.001 | -68.83%0.0024 | -191.16%-0.0866 | -1,394.85%-0.1689 |
| Dividend per share | 0 | 0 | 0.004 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.